New Snoring Therapy Awarded The Prestigious Spark Award
SAN JOSE, Calif., Nov. 8, 2012 /PRNewswire/ -- Ventus Medical announces that their Theravent Advanced Nightly Snore Therapy has received the prestigious Spark Award. Theravent won silver in the 2012 Spark competition for Product Design. The Spark Awards reward innovative design that helps humanity or the environment we live in. The mission of the award is to promote better living through better design.
(Photo: http://photos.prnewswire.com/prnh/20121108/SF08562 )
"The Theravent product is already helping a lot of couples get a better night's sleep," says Peter Wyles, CEO and President of Ventus Medical. "Ventus worked with LUNAR on developing the very innovative Theravent product and we were able to create an elegant design that gives people an easy to use solution to effectively treat their snoring. This is an important accomplishment in a market where 45 million people snore and their bed partners suffer."
"We are thrilled to see Theravent win this recognition," said John Edson, LUNAR's president. "This simple, ingenious product is the most recent result of a lot of hard work and an amazing collaboration between the teams at Ventus and LUNAR. Even more satisfying than the award is seeing these products help a lot of people."
Theravent is a unique, disposable nightly snoring device that is FDA-cleared to reduce or eliminate snoring. It has been proven to reduce snoring in clinical studies and is available without a prescription. On average, successful Theravent users reduced snoring by 76%, as measured using a decibel meter worn on the forehead. Theravent uses the same patented MicroValve Technology that was previously only available with a prescription. It is available exclusively